News
In its fourth quarter 2024 investor letter, TimesSquare Capital Management U.S. Focus Growth Strategy emphasized stocks such as Veeva Systems Inc. (NYSE:VEEV). Veeva Systems Inc. (NYSE:VEEV ...
PLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with ...
CHICAGO – 1 April, 2025 - EVERSANA, a global provider of commercial services to the life sciences industry, today announced it has been named an official Veeva AI Partner, managed by Veeva Systems, a ...
Boehringer Ingelheim and Veeva (VEEV) Systems have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of Veeva Development Cloud. They first ...
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases "Together with Veeva, Boehringer has advanced its approach to clinical ...
JPMorgan raised the firm’s price target on Veeva (VEEV) to $249 from $218 and keeps a Neutral rating on the shares. Veeva has a substantial addressable market at roughly $20B, and the company ...
I reaffirm my buy rating on Veeva Systems due to strong 4Q25 results, driven by R&D growth and positive Vault CRM adoption traction. VEEV's revenue grew 14% y/y to $721 million, beating ...
PLEASANTON, CA – Veeva Systems Inc. (NYSE:VEEV), a leader in cloud-based software for the global life sciences industry with a market capitalization of $38 billion, announced the upcoming ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results